BioNexus Gene Lab Corp BGLC:OTCQB

RT Quote | Exchange | USD
Last | 02/24/21 EST
2.10UNCH (UNCH)
Volume
50
52 week range
0.36 - 3.45

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.10
  • 52 Week High3.45
  • 52 Week High Date10/21/20
  • 52 Week Low0.36
  • 52 Week Low Date09/16/20
  • Market Cap359.56M
  • Shares Out171.22M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-758.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-208,000.00
  • ROE (MRQ)-24.33%
  • Revenue (MRQ)80,000.00
  • Gross Margin (MRQ)22.60%
  • Net Margin (MRQ)-321.59%
  • Debt To Equity (MRQ)6.38%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BioNexus Gene Lab Corp News

There is no recent news for this security.

Latest BGLC News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
BioNexus Gene Lab Corporation is a molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. The Company is engaged in developing and marketing non-invasive blood tests for early detection of diseases. The Company’s non-invasive blood tests analyze changes in ribonucleic acid (RNA) to detect the risk potentiality of over 11 different diseases. Bionexus Gene Lab Sdn. Bdh. is the subsidiary of...
Address
905 Broadway St Ste 100
Kuala Lumpur, WY
59200
Malaysia